ArticlePloS one2025
Causal associations between psoriasis and atopic dermatitis: A bidirectional Mendelian randomization study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Incident psoriasis in atopic dermatitis: a large-scale cohort study of disease- and treatment-associated risks.Frontiers in immunology · 2026Article
- Immunological Antagonism Between Psoriasis and Atopic Dermatitis: Pathways, Clinical Implications, and Therapeutic Perspectives.Clinical, cosmetic and investigational dermatology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough previous studies suggested associations between psoriasis and atopic dermatitis (AD), the directionality and causality of these relationships remain controversial. This study employed bidirectional Mendelian randomization to investigate the potential causal relationships between these two inflammatory skin conditions.
methodsGenome-wide association statistics were obtained for psoriasis and AD from large-scale consortia and meta-analyses of genome-wide association studies. Inverse-variance weighting, as the primary analysis, was combined with five complementary sensitivity analyses to evaluate the robustness and potential pleiotropy of the data. Additionally, we performed gene mapping of psoriasis-associated single-nucleotide polymorphisms and subsequent pathway analysis to further elucidate the potential relationships.
resultsGenetic predisposition to psoriasis was significantly associated with a decreased risk of AD (odds ratio = 0.876; 95% confidence interval = 0.834-0.921; p = 1.6 × 10-7). Conversely, genetic predisposition to AD did not affect the risk of psoriasis. The associations remained consistent across multiple sensitivity analyses, and no evidence of horizontal pleiotropy was observed. Gene mapping identified eight key genes (ENSG00000249738, ENSG00000291336, ENSG00000291338, ENSG00000285703, OR2W1-AS1, HLA-DQA1, FBXL18, and nitric oxide synthase 2 (NOS2) located on chromosomes 5, 6, 7 and 17. Notably, NOS2 emerged as a core gene involved in key biological processes, including the TCR signaling pathway and protein metabolism.
conclusionsThis comprehensive MR study provided evidence of the protective causal effect of psoriasis on the risk of AD, whereas no reverse causal relationship was noted. These findings enhanced our understanding of the relationship between psoriasis and Ad and identified potential implications for their clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.